Patient/caregiver was instructed upon therapeutic uses and mechanism of action of Rivaroxaban as follows
- Rivaroxaban is an anticoagulant inhibiting some proteins that help clotting.
- Rivaroxaban inhibits factor Xa, a very key factor, along the pathway of clot formation.
- Inhibition of factor Xa by Rivaroxaban further leads to inhibition of formation of several other proteins along the clotting pathway, thus making the blood thinner and less likely to clot.
- Rivaroxaban helps individuals with cardiac arrhythmias, such as, atrial fibrillation, by preventing formation of clot and consequent stroke.
- Inhibition of clot formation also offers protection against deep venous thrombosis, consequent development of pulmonary embolism and episodes of myocardial infarction and chest pain.
- So, Rivaroxaban is widely used in individuals undergoing hip and knee surgeries and other procedures that involve prolonged period of reduced mobilization and limited range of motion in the surgical limb and a high risk for development of deep venous thrombosis.
